US clinical trials start in animals, then move to ppl. Results often don't translate. Startups are moving abroad to jump to human trials sooner, hoping big risks will speed gene therapy R&D. Frank Swain's behind-the-scenes look at this is worth a read. wired.com/story/bioviva-…